膀胱输尿管返流VUR和泌尿道感染UTI的抗生素预防与治疗英文PPTVURUTIandAntibiotic

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Study Conclusions
Mild/moderate VUR not associated with UTI, pyelonephritis, or scarring
Antibiotic prophylaxis not associated with UTI, pyeloneprhitis, or scarring
Does antibiotic prophylaxis correlate with UTI/renal scarring?
Study Design
Randomized, controlled, multicenter trial Inclusion:
3mo-18yo Acute pyelonephritis
We Need A Study That…
Will help us decide whether or not to prophylax this patient
Includes patients with symptomatic VUR Compares antibiotic prophylaxis to a control Looks at clinically important outcomes
Study Results
Renal Scarring
No evidence VUR increased scarring (p=.9999)
VUR (6.2%) = No VUR (5.7%) Abx (7.0%) = No Abx (5.1%)
Grade I VUR – 5.3% with scars Grade II VUR – 5.2% Grade III VUR – 13.5%
Scarring +/-
+/+/-
+/-
+ +/-
Treatment Abx prophy
Abx prophy Unilat: abx Bilat: surgery Abx prophy Unilat: abx Bilat: surgery Surgery Surgery
Follow-Up No consensus Surgery Surgery
Kali is admitted to Wd51 for 48hrs of IV abx, then, afebrile, discharged to complete po course.
She undergoes renal US and VCUG 3 weeks later, which reveal grade II VUR on the left.
Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L.
Pediatrics 2006;117:626-632.
Study Questions
Does VUR correlate with UTI/renal scarring?
■ VUR UTI? ■ VUR Scarring?
Current Treatment Recs
Workup:
Febrile UTI (any age) UTI <5yo UTI x2 in school-age girls UTI in any boy
Imaging:
Renal US
Goal: p<.05!
http://www.childrensmercy.org/stats/ask/fishers.asp
Study Results
Recurrence of UTIs
Timing Type
Recurrent Pyelonephritis & Antibiotics Recurrent Pyelonephritis & VUR Degree Renal Scarring
Surgery Surgery
Current Treatment Recs
AUA Pediatric VUR Guidelines Panel (1997)
“The panel recommendations to offer continuous abx prophylaxis…are based on limited scientific evidence. To our knowledge controlled studies comparing the efficacy of continuous prophylaxis and intermittent therapy on health outcomes…have not been performed.”
Kali is admitted to Wd51 for 48hrs of IV abx, then, afebrile, discharged to complete po course.
The Case
Kali is a 14mo female who presents to WRAMC ED with fever to 102. Your stellar Peds Intern suggests obtaining a UA/UCx, which results in the diagnosis of acute pyelonephritis.
Type of Recurrence
Cystitis (no p value)
VUR – 8.6% No VUR – 13.3%
Pyelonephritis (p=.3781)
VUR – 7.1% No VUR – 3.8%
Study Results
Recurrent Pyelo and Antibiotics
No controlled studies? Then what are we basing treatment on?
The State of the Art
Williams et.al. (2001)
Systematic review of RCTs on UTI/abx prophy
Five trials, 1968-1978
Best 2: 71 patients total, normal anatomy, 92% girls
Garin et.al. (1998)
UTI VUR? no VUR UTI? no
Scars? VUR Scarring? no
■ VUR Pyelo? ■ Degree VUR
40% sensitive (VUR)
VCUG
Diagnostic!
DMSA
To treat or not to treat?
AUA Treatment Guidelines
Grade Age (y)
I-II
Any
III-IV 0-5 III-IV 6-10
V
<1
V
1-5
V
1-5
V
6-10
VUR, UTI, and Antibiotic Prophylaxis
How to Use an Article About Therapy or Prevention
Journal Club Amy K Evans PGY2
August 15, 2006
The Case
Kali is a 14mo female who presents to WRAMC ED with fever to 102. Your stellar Peds Intern suggests obtaining a UA/UCx, which results in the diagnosis of acute pyelonephritis.
Exclusion:ຫໍສະໝຸດ Baidu
Grade IV-V VUR Anatomic abnormalities Pregnancy
Study Design
Met inclusion criteria VCUG
VUR
Abx
No Abx
No VUR
Abx
No Abx
Pyelo treated: IV abx po for 14-day course Abx: TMP/SMX or nitrofurantoin for 1 year
VUR Antibiotics
Study Results
Recurrence of UTI
Overall – 20.1% VUR not significant No abx (p=.9999)
VUR – 22.4% No VUR – 23.3%
Abx (p=0.633)
VUR – 23.6% No VUR – 8.8%
Background
Incidence 1-10% Siblings 30-45% (3/4 asymptomatic) Diagnosed via VCUG
UTI workup – 40% (girls); 70% (infants <1yo) Antenatal hydronephrosis – 9% (boys)
Background
Vesicoureteral Reflux (VUR) Primary – congenital incompetence of VU valve
(shortened submucosal tunnel) Secondary – multiple anatomic abnormalities
Follow Up
At entry: UA/UCx, DMSA, VCUG, Renal US At Q3mo clinic visit: UA/UCx At 6mo: DMSA At 12mo: VCUG, Renal US
Endpoints:
Recurrent UTI Renal scarring
No benefit of abx (p=.0291) 7:1 abx:none
Recurrent Pyelo and VUR Degree
6/8 Grade III (cystitis: 46%) 2/8 Grade II (cystitis: 40%) 4/4 pts without VUR
Why worry?
VUR pyelonephritis renal scarring
HTN, renal insufficiency, ESRD, pre-eclampsia
Background
Natural hx of VUR: spontaneous resolution
UTI VUR? VUR Pyelo?
The Question
Should we treat her prophylactically?
Short-term:
Will this decrease recurrent infections?
Long-term:
Will this decrease renal scarring? Why else would it matter?
Clinical significance of primary vesicoureteral reflux and urinary antibiotic
prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.
Study Results
Analysis of Results
Fisher’s Exact Test
2x2 comparison tables Control vs. variable Smaller sample size Gives p value Does not give CI
The Case
Kali is a 14mo female who presents to WRAMC ED with fever to 102. Your stellar Peds Intern suggests obtaining a UA/UCx, which results in the diagnosis of acute pyelonephritis.
相关文档
最新文档